SHARE
COPY LINK

HEALTH

Indian Covid variant detected in Switzerland

A first case of the Covid-19 variant contributing to the exploding outbreak in India has been detected in Switzerland, the public health authority said Saturday.

geneva-airport
A man wearing a protective face mask rides his bicycle past the entrance of Geneva Airport amid the COVID-19 outbreak, caused by the novel coronavirus, on May 28, 2020, in Geneva. (Photo by Fabrice COFFRINI / AFP)

“The first case of the Indian variant of Covid-19 has been discovered in Switzerland,” Switzerland’s Federal Office of Public Health said in a tweet.

The virus variant was found in “a passenger who arrived in Switzerland after transiting through a European airport.”

The tweet from the Federal Office of Public Health (BAG) in German, one of Switzerland’s official languages

The health authority corrected its initial announcement to make it clear that the passenger had transited in another European country before travelling to
Switzerland, rather than transiting in Switzerland itself.

The correction in French issued by the health authority on Twitter

“The person changed flights in a European country before flying on to Switzerland,” spokesman Daniel Dauwalder confirmed to AFP in an email, adding that the positive sample was collected in March in the northern canton of Solothurn.
  
The Federal Office of Public Health is meanwhile discussing whether to add India to its “red list” of high-risk countries, it said on Saturday.

Only a few days earlier, Swiss Interior and Health Minister Alain Berset said the government had decided not to put India on the red list as there were no direct flights between the country and Switzerland currently, according to Swiss website 20 Minuten.

People arriving from countries placed on Switzerland’s red list are required to quarantine for 10 days.

But Dauwalder pointed out that India already figured on a separate list held by the State Secretariat for Migration, which meant that for now, in most cases, only Swiss citizens and residents were permitted to enter Switzerland after a stay in India.

Swiss Interior and health Minister Alain Berset (R) speaks with Head of the infectious diseases department at the Federal Office of Public Health Virginie Masserey Spicher following a press conference on January 6, 2021, in Bern. (Photo by Fabrice COFFRINI / AFP)

READ ALSO: Germany restricts travel from high-risk India

Switzerland puts countries and regions on the red list once Covid-19 infection rates remain significantly higher than Switzerland’s for a period of 14 days.

Furthermore, the World Health Organisation has so far only listed the variant as a “variant of interest”, that is one that is “suspected” to be either more contagious than the original strain, cause more severe disease, or escape the protection offered by vaccines.

Manfred Weber, Leader of the European People’s Party in the European Parliament, has called for all flights from India to the EU to be completely stopped, warning that the situation was getting out of control, German daily Bild reported.

Countries have been on high alert for the new “double mutant” variant, known as B.1.617, with several having already suspended flights from India.

More contagious variant?

There is concern that vaccines protect less effectively against this variant because of the two mutations in key areas of the virus’ spike protein.

Professor Paul Hunter, a professor in medicine at the University of East Anglia, told The Guardian that the arrival of the India variant was potentially worrying.

“These two escape mutations working together could be a lot more problematic than the South African and Brazilian variants who have only got one escape mutation,” he said. “It might be even less controlled by vaccine than the Brazilian and South African variants.”

However, other experts were less concerned.

“It is not possible to discern a reliable trend from the few observations we have, but we should observe it closely,” Richard Neher, Head of the Evolution of Viruses and Bacteria Research Group at the University of Basel’s Centre of Molecular Life Sciences, according to Stern magazine.

Given the lack of knowledge about the many variants with noteworthy mutations, Neher said he did not believe that the Indian variant deserved any more concern than others.

Christian Drosten, a virologist at Berlin’s Charité teaching hospital, also did not see the new variant as a cause for concern, he said in an NDR podcast at the end of March.

READ ALSO: MAPS: Where in Switzerland are the highest and lowest Covid rates?

Since the start of the pandemic, in Switzerland and Liechtenstein, 646,509 people have tested positive for Covid-19 and 9,955 people have died from the virus, according to the Swiss Federal Office of Public Health.

As of April 21st, 9.8 percent of the population had been fully vaccinated against coronavirus with two doses of a vaccine.

The news of the variant’s arrival in Switzerland comes after Belgian authorities on Thursday said a group of 20 Indian nursing students who arrived from Paris had tested positive for the variant in the country.

India’s healthcare system is meanwhile buckling under a new wave of infections.

On Saturday, Covid-19 case numbers and deaths in the country set another grim new record.

The number of deaths across India climbed by 2,624 in the 24 hours to Saturday, up from Friday’s 2,263, as the country struggles to cope amid full intensive care units and a shortage of oxygen supplies.

A total of almost 190,000 people have died of coronavirus in India, according to official figures.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

HEALTH

Switzerland tries slow-mo cannabis revolution

Switzerland, which pioneered prescription heroin and safe injection sites decades ago, is now experimenting with decriminalising recreational cannabis, with the drug now available in some Basel pharmacies.

Switzerland tries slow-mo cannabis revolution

“This is 1,000 times better,” said Paul, a 42-year-old resident of the northern Swiss city, as he picked up a package of cannabis from his local pharmacy.

After buying his drug of choice on the street from “weird people or criminals” for the past 25 years, Paul, who asked that his last name not be published, is taking part in a pilot programme allowing him to acquire it over the counter.

“People are happy, since they for the first time can buy it legally,” pharmacist Lucas Meister told AFP, showing off a stash of colourful packages containing various dried cannabis flowers and hashish-based products.

His is one of nine pharmacies that have been chosen to take part in the two-year pilot for the legal sale of recreational cannabis.

Thousands of people applied to take part in the trial, but Paul, who mainly uses the drug to treat his depression, was among just 400 chosen.

Not encouraging consumption

Cannabis is legal for medical use in the wealthy Alpine nation, but only in extreme cases, such as pain relief for cancer patients.

Low-potency cannabis can also be purchased legally for non-medical use, but only when it contains below one percent tetrahydrocannabinol (THC) – the
component that gets recreational users high.

And while more potent cannabis is illegal, carrying up to 10 grammes of more potent cannabis for one’s own consumption is not punishable by law.

But while there are already a few ways to consume the drug without risking run-ins with police, pressure has been mounting for legalisation.

Paul smokes at home cannabis with a vaporizer during a two-year pilot for the legal sale of recreational cannabis in Basel, on March 7th, 2023.

Paul smokes at home cannabis with a vaporizer during a two-year pilot for the legal sale of recreational cannabis in Basel, on March 7th, 2023. (Photo by Fabrice COFFRINI / AFP)

In 2021, around 70 percent of the population favoured liberalising the laws, up from 58 percent three years earlier, according to the Swiss health ministry.

“We have to get out of the illicit cannabis framework, but ensure strict regulation,” said Barbara Broers, vice president of a federal commission on issues surrounding addiction.

“It is important that people have access to controlled and regulated products, but we are proposing to ban advertising and to have plain packaging, as with cigarettes in some countries,” she told AFP.

“This is not about encouraging consumption.”

Small steps

The Swiss government has opted for a small-steps approach, and authorised trials to take place over the coming decade.

In Basel, participants are aged 18 to 76, and the aim is to study “the effects of regulated cannabis sale… on mental health and on consumption behaviour,” Marc Walter, a psychiatry professor at the University of Basel and head of the study, told AFP.

So far, participants have been especially drawn to “products with a very high level of THC,” he said.

The five-gramme packs that Meister keeps in his pharmacy safe contain products with THC levels ranging from 4.5 to 20 percent.

They are priced at between eight and 12 Swiss francs ($8.70-$13) per gramme, depending on the THC level, in line with black market pricing.

The pricing level was very deliberate, according to Marc Brungger, an executive at the Swiss company Pure Production, which is producing cannabis
for the Basel trial.

“If prices are too low, people would try to resell the product, and if they are too high, they would turn to the black market,” he told AFP.

Other major Swiss cities, including Zurich, Geneva and Lausanne, are planning to launch similar trials.

‘Pure and organic’

In Basel, Paul said he is thrilled to leave street dealers behind and to finally know with certainty what he is getting: “Pure and organic cannabis”, grown in Switzerland and quality-guaranteed by the Swiss authorities.

“I want to consume cannabis, not chemicals made in China,” he told AFP, voicing horror at the arrival on the street of synthetic cannabinoids – laboratory-made molecules that mimic the THC effect.

The marketing specialist said it was a shame Switzerland had not taken a more direct route to legalisation, as in some US states, Canada and Uruguay.

But Walter said he was happy “Switzerland has chosen another route”.

“As a scientist, I prefer that.”

Frank Zobel, head of Addiction Switzerland, agreed, pointing out that taking things slow and steady to see how the population responds was a very Swiss approach.

That model proved itself in the 1990s, he said, noting how Switzerland had slowly introduced prescribing heroin for medical use.

“There too, there were four years of pilot trials, and today it is a treatment that is covered by medical insurance,” he said.

By Agnès PEDRERO

SHOW COMMENTS